Comparison of effectiveness of angiotensin-converting enzyme inhibitors after acute myocardial infarction in diabetic versus nondiabetic patients

American Journal of Cardiology

Volumn 92, Issue 9, 2003, Pages 1020-1025

  Gottlieb, Shmuel ^a   Leor, Jonathan ^b   Shotan, Avraham ^b   Harpaz, David ^b   Boyko, Valentina ^b   Rott, David ^b   Mandelzweig, Lori ^b   Behar, Solomon ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY CARE UNIT; CORONARY RISK; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; EVALUATION; FEMALE; HAZARD ASSESSMENT; HEALTH SURVEY; HEART PROTECTION; HUMAN; INTERMETHOD COMPARISON; ISRAEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF COVARIANCE; POPULATION RESEARCH; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0142227161     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.07.002     Document Type: Article

References (13)

1. Schulman S.P., Weiss J.L., Becker L.C., Guerci A.D., Shapiro E.P., Chandra N.C., Siu C., Flaherty J.T., Coombs V., Taube J.C., et al. Effect of early enalapril therapy on left ventricular function and structure in acute myocardial infarction. Am J Cardiol. 76:1995;764-770.
2. Moye LA, Pfeffer MA, Wun CC, Davis BR, Geltman E, Hayes D, Farnham DJ, Randall OS, Dinh H, Arnold JM, et al, for the SAVE Investigators. Uniformity of captopril benefit in the SAVE study: subgroup analysis. Eur Heart J 1994;15(suppl B):2-8.
3. Zuanetti G., Latini R., Maggioni A.P., Franzosi M., Santoro L., Tognoni G. Effect of the ACE inhibitor lisinopril on mortality in diabetic patients with acute myocardial infarction data from the GISSI-3 study. Circulation. 96:1997;4239-4245.
4. Gustafssoon I., Torp-Pedersen C., Kober L., Gustafssoon F., Hildebrandt P. Effect of the angiotensin converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular infarction. J Am Coll Cardiol. 34:1999;83-89.
5. Gottlieb S., Harpaz D., Shotan A., Boyko V., Leor J., Cohen M., Mandelzweig L., Mazouz B., Stern S., Behar S. Sex differences in management and outcome after acute myocardial infarction in the 1990s a prospective observational community-based study. Circulation. 102:2000;2484-2490.
6. Shekelle P.G., Rich M.W., Morton S.C., Atkinson C.S.W., Tu W., Maglione M., Rhodes S., Barrett M., Fonarow G.C., Greenberg B., et al. Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender and diabetes status a meta-analysis of major clinical trials. J Am Coll Cardiol. 41:2003;1529-1538.
7. The Heart Outcome Prevention Evaluation (HOPE) Study Investigators. Effects of angiotensin converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000;342:145-153.
8. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE substudy. Lancet. 355:2000;253-259.
9. Hansson L., Lindholm L.H., Niskanen L., Lanke J., Hedner T., Niklason A., Luomanmaki K., Dahlof B., de Faire U., Morlin C., et al. Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension the Captopril Prevention Project (CAPPP) randomized trial. Lancet. 353:1999;611-616.
10. Pahor M., Psaty B.M., Aldeman M.H., Applegate W.B., Williamson J.D., Furberg C.D. Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care. 23:2000;888-892.
11. Lewis E.J., Hunsicker L.G., Bain R.P., Rohde R.D. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med. 329:1993;1456-1462.
12. Maschio G., Alberti D., Janin G., Locatelli F., Mann J. FE, Motolese M., Ponticelli C., Ritz E., Zucchelli P. Effect of the angiotensin-converting- enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med. 334:1996;939-945.
13. Barron H.V., Michaels A.D., Maynard C., Every N.R. Use of angiotensin-converting enzyme inhibitors at discharge in patients with acute myocardial infarction in the United States data from the National Registry of Myocardial Infarction 2. J Am Coll Cardiol. 32:1998;360-367.